(AOF) – Néovacs announces the signing of a collaboration agreement with the CNRS. In detail, the biotech, which develops new therapies for inflammatory and autoimmune diseases, announces the signing of a collaboration and research contract with the team of Dr. Nathalie Mignet, research director at the CNRS (laboratory ” Chemical and Biological Technologies for Health Unit”), CNRS, Paris Cité University and Inserm, for the joint development of new lipid formulations for the delivery of messenger RNA (mRNA).
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
